AE	Adverse event
α-MSH	α-melanocyte-stimulating hormone
BCC	Basal cell carcinoma
CTLA-4	Cytotoxic T cell lymphocyte associated protein-4
DHH	Desert hedgehog
FDA	Food and Drug Administration
GLI	Glioma associated oncogene
HHI	Hedgehog inhibitor
HIP	Hedgehog interacting protein
IHH	Indian hedgehog
laBCC	Locally advanced basal cell carcinoma
LAG-3	Lymphocyte activation gene 3
mBCC	Metastatic basal cell carcinoma
MC1R	Melanocortin 1 receptor
NBCCS	Nevoid basal cell carcinoma syndrome
NNMT	Nicotinamide N-methyltransferase
ORR	Overall response rate
PD-1	Programmed death-1
PD-L1	Programmed death-ligand 1
PD-L2	Programmed death-ligand 2
PDT	Photodynamic therapy
PON2	Paraoxonase-2
PTCH1	Patched 1
RR	Response rate
SHH	Sonic hedgehog
SMO	Smoothened
SUFU	Suppressor of fused
TCR	T cell receptor
TIM-3	T-cell immunoglobulin and mucin domain-3
TMB	Tumor mutational burden
UV	Ultraviolet